The Future of Melanoma: What to Anticipate in 2022

The Future of Melanoma: What to Anticipate in 2022 With Anthony J. Olszanski, MD, RPh and Jeffrey M. Farma, MD, FACS, co-directors of Fox Chase Cancer Center’s Melanoma and Skin Cancer Program. Drs. Farma and Olszanski will discuss: - new surgical and systemic options for the treatment of patients with melanoma; - the role of neoadjuvant therapy prior to surgery; - how it is determined which patients are considered for neoadjuvant therapy; - two case studies “I believe that the path towards treating any disease is best navigated by thoroughly understanding not only the disease, but also the patient. Good communication between a physician and a patient is especially critical in the treatment of cancer. Each patient has a right to be both respected and heard. In addition, relying on a team of experts to help manage the complexities of treating cancer is essential for success. As a physician, I strive to provide personalized and scientifically sound care to each of my patients.“ Anthony J. Olszanski, MD, RP “